Marie Knockaert
Co-founder, ANAGENESIS Biotechnologies
Biotechnology
Clinical Research
France
Biography
Consultant since december 2014, Marie Knockaert helds the position of COO for Anagenesis from december 2013 to november 2014. Marie Knockaert did her PhD in the field of anti-cancer drug development studying the intracellular mechanism of action of candidate-drugs prior to preclinical testing initiation. She then did a post-doc in the laboratory of Pr Ali Brivanlou at the Rockefeller University (New York) where she specialized in human stem cell biology. From 2009 to 2013, she worked in Olivier Pourquié’s group where she coordinated the 4-year strategic project funded by AFM (the French Muscular Dystrophy Association) at the origin of Anagenesis’ princeps technology.
Research Interest
human stem cell biology
